Search filters

List of works by Ibrahim Aldoss

Acute Lymphoblastic Leukemia in the Older Adult

scientific article published on 01 February 2019

Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma

scientific article published on 19 July 2018

Adults with Philadelphia-Like Acute Lymphoblastic Leukemia: Considerations for Allogeneic Hematopoietic Cell Transplantation in First Complete Remission

article

Advances in adult acute lymphoblastic leukemia therapy

scientific article published on 26 July 2017

Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase Mutations.

scientific article published on 26 April 2019

Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia.

scientific article published on 7 April 2017

An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemia.

scientific article

Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

scientific article published on 10 July 2019

CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies

scientific article published on 01 September 2019

Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital

scientific article published on 28 February 2020

Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)

scientific article published in 2022

Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia.

scientific article published on 23 April 2019

Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia

scientific article published on 11 May 2017

Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

scientific article published on April 2016

Cytokine Release Syndrome With the Novel Treatments of Acute Lymphoblastic Leukemia: Pathophysiology, Prevention, and Treatment

scientific article published on 21 January 2019

Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

scientific article published on 23 June 2016

Donor-derived myeloid neoplasm post allogeneic hematopoietic cell transplantation

scientific article published in March 2017

Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

scholarly article by Ibrahim Aldoss et al published September 2018 in Haematologica

Extramedullary relapse of KMT2A(MLL)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab

scientific article published on 01 May 2018

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status

scientific article published on 29 September 2017

Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemia

scientific article published on 14 May 2019

Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia

scientific article published on 14 September 2020

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

scientific article

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults

scientific article published on 21 November 2016

How I treat adults with advanced acute lymphoblastic leukemia eligible for CD19-targeted immunotherapy

scientific article published on 01 March 2020

How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia

scientific article published on 01 March 2020

Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor Rescue

scientific article published on 18 April 2017

Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for use

scientific article published on 13 December 2018

Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

scientific article

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blo

scientific article published on 26 September 2019

Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia.

scientific article published on 19 October 2015

Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD?

scientific article published on 16 November 2018

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia

scientific article published on 29 November 2017

Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

scientific article published on 01 December 2019

Iron Overload is Associated with Delayed Engraftment and Increased Non-Relapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation

scientific article published on 10 June 2020

Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-

scientific article published on 16 September 2019

Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.

scientific article

Long-term Outcomes of Allogeneic Hematopoietic Cell transplantation with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as GVHD prophylaxis in Patients with Acute Lymphoblastic Leukemia

scientific article published on 13 May 2020

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults

scientific article

More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine

scientific article published on 01 October 2019

Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy

scientific article published on 01 October 2020

Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic Leukemia.

scientific article

Outcome of allogeneic hematopoietic cell transplantation after venetoclax and hypomethylating agent therapy for acute myeloid leukemia

scientific article published on 28 August 2020

Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

scientific article published on 05 February 2020

Outcomes of Therapy with Venetoclax Combined with A Hypomethylating Agent in Favorable-Risk Acute Myeloid Leukemia

scientific article published on 23 November 2020

Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses

scientific article

Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia

scientific article

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia

scientific article

Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.

scientific article

Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones

scientific article published on 29 January 2019

Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis

scientific article published on 06 November 2019

Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin

scientific article published on 19 March 2020

Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab

scientific article published on 01 May 2020

Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with NUP214-ABL1

scientific article published on 24 April 2019

Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy

scientific article published on 19 August 2020

Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia

scientific article published on 01 December 2020

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

scientific article published on 01 October 2020

Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia

scientific article published on 23 July 2019

Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia

scientific article published on 21 July 2020

The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML

scientific article published on 08 January 2019

The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement

scientific article published on 19 March 2020

The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implications

scientific article published on 14 August 2018

The feasibility of venetoclax and decitabine in therapy-related acute myeloid leukemia with concurrent advanced non-hematological malignancies

scientific article published on 30 July 2019

Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients

scholarly article by Ibrahim Aldoss et al published October 2018 in Haematologica

Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?

scientific article published on 19 June 2019

Therapy-related acute myeloid leukemia with favorable cytogenetics: still favorable?

scientific article published on 29 September 2012

Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia

scientific article published on 10 June 2015

Tumor intrinsic and extrinsic determinants of response to blinatumomab in adults with B-ALL

scientific article published on 03 September 2020

Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia

scientific article published on 06 July 2020

Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia

scientific article published on 22 August 2019

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial

scientific article

Paulina is supported by:

About Paulina

Help